![](/img/cover-not-exists.png)
A Phase I Safety and Pharmacokinetic Study of the Death Receptor 5 Agonistic Antibody PRO95780 in Patients with Advanced Malignancies
Camidge, D. R., Herbst, R. S., Gordon, M. S., Eckhardt, S. G., Kurzrock, R., Durbin, B., Ing, J., Tohnya, T. M., Sager, J., Ashkenazi, A., Bray, G., Mendelson, D.Volume:
16
Language:
english
Journal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-09-1267
Date:
February, 2010
File:
PDF, 274 KB
english, 2010